Scarica l'app Stockscreener
10.53
11.08%
1.05
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TPST Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$9.48
Aprire:
$9.5
Volume 24 ore:
222.17K
Relative Volume:
1.76
Capitalizzazione di mercato:
$38.78M
Reddito:
-
Utile/perdita netta:
$-31.11M
Rapporto P/E:
-6.8824
EPS:
-1.53
Flusso di cassa netto:
$-28.18M
1 W Prestazione:
+43.07%
1M Prestazione:
+57.40%
6M Prestazione:
-12.91%
1 anno Prestazione:
-47.74%
Intervallo 1D:
$9.3013
$10.90
Intervallo di 1 settimana:
$7.65
$10.90
Portata 52W:
$5.3495
$20.67
Tempest Therapeutics Inc Stock (TPST) Company Profile
Nome
Tempest Therapeutics Inc
Settore
Industria
Telefono
415-798-8589
Indirizzo
2000 SIERRA POINT PARKWAY, BRISBANE
Confronta TPST con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TPST
Tempest Therapeutics Inc
|
10.53 | 42.09M | 0 | -31.11M | -28.18M | -1.53 |
|
VRTX
Vertex Pharmaceuticals Inc
|
392.79 | 100.07B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.41 | 59.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
448.91 | 58.03B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
653.83 | 39.93B | 3.06B | 1.28B | -614.78M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
321.36 | 36.82B | 3.81B | -644.79M | -669.77M | -6.24 |
Tempest Therapeutics Inc Stock (TPST) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-10 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2025-04-10 | Downgrade | Scotiabank | Sector Outperform → Sector Perform |
| 2024-03-14 | Iniziato | Scotiabank | Sector Outperform |
| 2024-02-08 | Iniziato | Jefferies | Buy |
Tempest Therapeutics Inc Borsa (TPST) Ultime notizie
What momentum shifts mean for Tempest Therapeutics Inc.Portfolio Gains Report & Daily Growth Stock Investment Tips - Newser
Using economic indicators to assess Tempest Therapeutics Inc. potentialMarket Movement Recap & Consistent Profit Trade Alerts - Newser
Using data tools to time your Tempest Therapeutics Inc. exitJuly 2025 Trends & Momentum Based Trading Ideas - Newser
Tempest Therapeutics Inc. stock chart pattern explainedMarket Risk Analysis & Safe Capital Growth Trade Ideas - Newser
What makes Tempest Therapeutics Inc. stock price move sharplyJuly 2025 Fed Impact & AI Powered Market Entry Strategies - Newser
Can machine learning forecast Tempest Therapeutics Inc. recoveryEarnings Beat & Free Weekly Watchlist of Top Performers - Newser
Exit strategy if you’re trapped in Tempest Therapeutics Inc.Market Risk Report & Community Trade Idea Sharing Platform - Newser
Top chart patterns to watch in Tempest Therapeutics Inc.Entry Point & Free Community Consensus Stock Picks - Newser
Quantitative breakdown of Tempest Therapeutics Inc. recent moveWeekly Profit Summary & Risk Managed Investment Entry Signals - Newser
How Interest Rate Changes Impact Tempest Therapeutics Inc. Stock PerformanceQuarterly Earnings Report & Reliable Volume Spike Trade Alerts - Newser
Why Tempest Therapeutics Inc. stock attracts strong analyst attentionMarket Performance Recap & Smart Swing Trading Alerts - Newser
Custom watchlist performance reports with Tempest Therapeutics Inc.2025 Winners & Losers & Growth Focused Stock Pick Reports - Newser
Real time alert setup for Tempest Therapeutics Inc. performanceTrade Ideas & High Accuracy Swing Entry Alerts - Newser
Pattern recognition hints at Tempest Therapeutics Inc. upsideJuly 2025 EndofMonth & High Accuracy Swing Entry Alerts - Newser
Can swing trading help recover from Tempest Therapeutics Inc. lossesTrade Volume Report & Short-Term Trading Opportunity Alerts - Newser
How institutional ownership impacts Tempest Therapeutics Inc. stockEarnings Summary Report & Daily Oversold Stock Bounce Ideas - Newser
Tempest Therapeutics Inc. stock outlook for YEAR2025 Bull vs Bear & Smart Money Movement Tracker - Newser
Analyzing drawdowns of Tempest Therapeutics Inc. with statistical toolsGDP Growth & Stock Portfolio Risk Control - Newser
Is Tempest Therapeutics Inc. forming a reversal patternWeekly Market Report & Technical Pattern Based Signals - Newser
Is Tempest Therapeutics Inc. stock a growth or value playAnalyst Upgrade & Free High Accuracy Swing Entry Alerts - Newser
Tempest Therapeutics Inc. Building a Base Near SupportAnalyst Upgrade & Entry and Exit Point Strategies - newsyoung.net
What data driven models say about Tempest Therapeutics Inc.’s futureMarket Sentiment Summary & Reliable Entry Point Alerts - Newser
Technical analysis overview for Tempest Therapeutics Inc. stockJuly 2025 Short Interest & Low Risk Growth Stock Ideas - Newser
Is Tempest Therapeutics Inc. stock bottoming out2025 Market Outlook & Fast Momentum Stock Entry Tips - Newser
Predicting Tempest Therapeutics Inc. trend using moving averagesFree Entry Alert With Low Drawdown Strategy - Newser
Is Tempest Therapeutics Inc. a play on infrastructure spendingBottom Formation Alert - thegnnews.com
Tempest Therapeutics Reports Q2 2025 Financial Results - TipRanks
Tempest Therapeutics TPST 2025Q2 Earnings Preview Downside Risk Amid Uncertain Revenue Expectations - AInvest
Tempest Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Tempest Therapeutics reports Q2 EPS ($2.07), consensus ($2.65) - TipRanks
Tempest Therapeutics: A Case Study in Operational Turnaround and Biotech Resilience - AInvest
Tempest Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire
Tempest Secures Triple Regulatory Wins for Cancer Drug Amezalpat as Q2 Losses Narrow - Stock Titan
Is it too late to sell Tempest Therapeutics Inc.Pattern Recognition Tool for ROI Investors - Newser
Tempest Therapeutics Inc Azioni (TPST) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.41%
0.88%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):